| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Poseida Therapeutics, Inc.
13G/A
PSTX · 73730P108
|
0% |
1/15/2025
Event 1/8/2025
|
||||
| Malin Life Sciences Holdings Limited | 0% | |||||
| Malin Corporation plc | 0% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.